Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
25.79
+0.38 (1.50%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $427.35 million as of June 9, 2026. Its market cap has increased by 449.97% in one year.
Market Cap
427.35M
Enterprise Value
238.43M
1-Year Change
449.97%
Ranking
Category
Stock Price
$25.79
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has increased from $346.92M to $427.35M, an increase of 23.18%. That is a compound annual growth rate of 2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 427.35M | 333.55% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 448.14M |
| Assembly Biosciences | 446.98M |
| Ovid Therapeutics | 440.47M |
| Contineum Therapeutics | 431.06M |
| Ocugen | 426.54M |
| Rezolute | 426.22M |
| Adlai Nortye | 409.20M |
| Monopar Therapeutics | 406.01M |